Search Results - "BENEVOLENSKAYA, L."

Refine Results
  1. 1
  2. 2

    Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women by Stakkestad, J A, Benevolenskaya, L I, Stepan, J J, Skag, A, Nordby, A, Oefjord, E, Burdeska, A, Jonkanski, I, Mahoney, P

    Published in Annals of the rheumatic diseases (01-10-2003)
    “…Objective: To investigate the efficacy, safety, and dose response of three doses of ibandronate, given intermittently by intravenous (IV) injection every three…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study by Lunt, M, Masaryk, P, Scheidt-Nave, C, Nijs, J, Poor, G, Pols, H, Falch, J A, Hammermeister, G, Reid, D M, Benevolenskaya, L, Weber, K, Cannata, J, O'Neill, T W, Felsenberg, D, Silman, A J, Reeve, J

    Published in Osteoporosis international (01-09-2001)
    “…The risk of low and moderate energy fracture is related to bone mineral density (BMD). Yet it is uncertain whether the epidemiologic determinants of fracture…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Determinants of the Size of Incident Vertebral Deformities in European Men and Women in the Sixth to Ninth Decades of Age: The European Prospective Osteoporosis Study (EPOS) by Reeve, J

    Published in Journal of bone and mineral research (01-09-2003)
    “…More severe vertebral fractures have more personal impact. In the European Prospective Osteoporosis Study, more severe vertebral collapse was predictable from…”
    Get full text
    Journal Article
  12. 12

    The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study by O'Neill, T. W., Felsenberg, D., Varlow, J., Cooper, C., Kanis, J. A., Silman, A. J.

    Published in Journal of bone and mineral research (01-07-1996)
    “…Our aim was to determine the prevalence of radiographically defined vertebral deformity, as a marker of vertebral osteoporosis, in different regions and…”
    Get full text
    Journal Article
  13. 13

    Population-based geographic variations in dxa bone density in Europe: The evos study by Lunt, M., Felsenberg, D., Adams, J., Benevolenskaya, L., Cannata, J., Dequeker, J., Dodenhof, C., Falch, J. A., Johnell, O., Khaw, K. T., Masaryk, P., Pols, H., Poor, G., Reid, D., Scheidt-Nave, C., Weber, K., Silman, A. J., Reeve, J.

    Published in Osteoporosis international (01-01-1997)
    “…The purpose of this study was to investigate variations in bone density between 16 European populations, 13 of which were participants in the European…”
    Get full text
    Journal Article
  14. 14

    Falls explain between-center differences in the incidence of limb fracture across Europe by Roy, D.K, Pye, S.R, Lunt, M, O’Neill, T.W, Todd, C, Raspe, H, Reeve, J, Silman, A.J

    Published in Bone (New York, N.Y.) (01-12-2002)
    “…There is important geographic variation in the occurrence of the major osteoporotic fractures across Europe. The aim of this study was to determine whether…”
    Get full text
    Journal Article
  15. 15

    The Relationship Between Bone Density and Incident Vertebral Fracture in Men and Women by O'Neill, T W, Lunt, M, Silman, A J, Felsenberg, D, Benevolenskaya, LI, Bhalla, A K, Cannata, J B, Cooper, C, Crabtree, N, Dequeker, J, Hoszowski, K, Jajic, I, Kanis, JA, Reeve, J

    Published in Journal of bone and mineral research (01-12-2002)
    “…Bone mineral density (BMD) is an important predictor of future fracture risk in women; however, there are few prospective data in men. The aim of this analysis…”
    Get full text
    Journal Article
  16. 16

    Estrogenic receptors a and p gene polymorphisms in postmenopausal osteoporosis by Maslova, K A, Krylov, M Y, Toroptsova, N V, Nikitinskaya, O A, Korotkova, T A, Myakotkin, V A, Benevolenskaya, L L

    “…Objective. To assess frequency distribution of estrogenic receptor (ER)a and ERfl gene polymorphisms and their influence on bone mineral density (BMD) in…”
    Get full text
    Journal Article
  17. 17

    Efficacy and safety of ibandronat tablets for treatment of postmenopausal osteoporosis by Toroplsova, N. V., Benevolenskaya, L L, Nikilinskaya, O A, Demin, N V

    “…Objective. To study efficacy and safety of ibandronat, highly active nitric-containing bisphosphonat in 3-year treatment of pts with postmenopausal…”
    Get full text
    Journal Article
  18. 18
  19. 19

    OSTEOPOROSIS AND C-REACTIVE PROTEIN by Anikin, S G, Benevolenskaya, L I, Aleksandrova, E N

    “…A chronic inflammatory process is one of the risk factors of secondary osteoporosis (OP) and its related fractures. Determination of the level of C-reactive…”
    Get full text
    Journal Article
  20. 20

    LEPTIN A19G POLYMORPHISM AND LEPTIN RECEPTOR Gln223Arg AND Lys109Arg POLYMORPHISMSIN POSTMENOPAUSAL OSTEOPOROSIS by Krylov, Mikhail Yur'evich, Benevolenskaya, L I, Myakotkin, V A, Krylov, Mikhail Yuryevich

    “…Objective: to study an association of leptin (LEP) A19G polymorphism and leptin receptor (LEPR) Gln223Arg AND Lys109Arg polymorphisms with the predilection for…”
    Get full text
    Journal Article